United States · FDA National Drug Code directory
Tadalafil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-603_14c0a7a9-5273-4ee8-e063-6294a90a13dc
- Product NDC
- 71610-603
- Form
- TABLET, FILM COATED
- Composition / generic term
- Tadalafil
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210121
- Source listing expiry
- 20261231
Source-listed ingredients
- TADALAFIL — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 8 TABLET, FILM COATED in 1 BOTTLE (71610-603-08) · 71610-603-08
- 48 TABLET, FILM COATED in 1 BOTTLE (71610-603-11) · 71610-603-11
- 16 TABLET, FILM COATED in 1 BOTTLE (71610-603-23) · 71610-603-23
- 2940 TABLET, FILM COATED in 1 BOTTLE (71610-603-36) · 71610-603-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →